Ashish M. Kamat

Dr. Ashish M. Kamat is a Senior Professor at The University of Texas MD Anderson Cancer Center, specializing in urologic oncology and surgical oncology. His research focuses on bladder cancer treatment paradigms, including systemic immunotherapy for BCG-naïve non–muscle-invasive bladder cancer, bladder preservation strategies, and therapeutic advancements in metastatic urothelial carcinoma. He leads trials combining radiotherapy with enfortumab vedotin and investigates homologous recombination deficiency signatures for PARP inhibitor applications. His recent publications in the Journal of Clinical Oncology and Nature Reviews Clinical Oncology explore real-world survival improvements and genomic landscapes of genitourinary cancers.